Healthcare: The Best Buys in Biopharma
Industry Focus
The Motley Fool
4.6 • 854 Ratings
🗓️ 11 May 2016
⏱️ 27 minutes
🧾️ Download transcript
Summary
GlaxoSmithKline takes on Pfizer and Biogen battles Celgene in this healthcare edition of Industry Focus.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Best Buyes in BioFarma. This is industry focus. |
| 0:11.3 | Welcome to the show. I'm your host Christine Hargis. It is May 11th, 2016 and I'm joined |
| 0:17.1 | as per usual by Motley Fool Healthcare Contributor Todd Campbell via Skype. |
| 0:21.3 | Hi Todd. |
| 0:22.3 | Hi, hi Todd. |
| 0:22.6 | Hi Christine, it's beautiful here. |
| 0:24.9 | Is it nice down in Alexandria? |
| 0:27.0 | No, definitely not. |
| 0:28.2 | I think I heard this is the single rainiest stretch of days |
| 0:31.4 | we've ever had in a spring. Or, you know, don't quote me on that, but it has been pretty. a next week so it's sunshine every day there. |
| 0:43.0 | Yay! |
| 0:44.0 | So for today's show, it is on the heels of earning season, |
| 0:48.0 | so we thought that we would take a look at four popular health care |
| 0:51.0 | companies today and pit them against each other, Battle Royale |
| 0:55.1 | style. Two are widely known Big Pharma and two are some of the largest biotex. Within each category, |
| 1:01.4 | which is the better by? You will have our answers by the end of this show. |
| 1:06.2 | So say you want to buy a household name, Big Pharma. Can I get a drum roll, please, Todd Todd as I announce today's contenders? |
| 1:14.5 | Glaxo Smith Klein and Pfizer. |
| 1:19.0 | Let's give a new review of each company and then pick a winner. |
| 1:22.0 | First up, let's do Glaxo. This is |
| 1:25.6 | going to be an interesting conversation. We're going to have a lot of fun |
| 1:28.3 | talking about it. We've got two Goliaths up against each other in pharmaceuticals and you've got two companies that are kind of diverging, |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.